Phillip Altman
Fondatore presso ARCS Australia Ltd.
Profilo
Phillip Altman is the founder of Pharmaco Pty Ltd., ARCS Australia Ltd.
He worked as a Non-Executive Director at Viralytics Pty Ltd.
from 2009 to 2014.
Altman received his undergraduate, graduate, and doctorate degrees from The University of Sydney.
Posizioni attive di Phillip Altman
| Società | Posizione | Inizio |
|---|---|---|
| ARCS Australia Ltd. | Fondatore | 10/12/2010 |
Precedenti posizioni note di Phillip Altman
| Società | Posizione | Fine |
|---|---|---|
| VIRALYTICS LTD. | Direttore/Membro del Consiglio | 01/09/2014 |
| Pharmaco Pty Ltd. | Fondatore | - |
Formazione di Phillip Altman
| The University of Sydney | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
| Pharmaco Pty Ltd. | |
| ARCS Australia Ltd. |
- Borsa valori
- Insiders
- Phillip Altman
